The phase 2 study aimed to compare the safety of pembrolizumab and radiation with or without olaparib in this high-risk population.
Zin Myint, MD
Advertisement
Articles by Zin Myint, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Accelerated Approval to Zongertinib in HER2+ NSCLC
2
Enzalutamide/Radium-223 Extends Survival in mCRPC
3
Enfortumab Vedotin Combo Boosts MIBC Survival Outcomes in EV-304 Trial
4
Overcoming Challenges to Access for Proton-Based Radiotherapy in OPSCC
5